Oct 14, 2026 08:00AM
Sep 26, 2026 10:28AM
Sep 18, 2026 09:00AM
Sep 16, 2026 09:01AM
Sep 16, 2026 09:00AM
Sep 15, 2026 07:30AM
Sep 15, 2026 07:30AM BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
Sep 14, 2026 04:01PM
Sep 14, 2026 04:01PM
Aug 22, 2026 10:40AM
Aug 14, 2026 09:00AM
Aug 8, 2026 12:00PM
Aug 7, 2026 09:00AM
Aug 6, 2026 07:30AM BioVie's bezisterim shows Phase 2 gains in Parkinson's trial
Aug 6, 2026 07:30AM
May 29, 2026 09:00AM
May 27, 2026 08:00AM
May 26, 2026 08:01AM
May 26, 2026 08:00AM
May 18, 2026 08:01AM
May 18, 2026 08:00AM BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease
Apr 27, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 14, 2026 08:00AM
Mar 12, 2026 08:00AM
Feb 27, 2026 09:00AM
Feb 23, 2026 08:00AM
Feb 21, 2026 10:45AM New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America
Feb 12, 2026 08:00AM
Jan 8, 2026 08:03AM
Jan 8, 2026 08:00AM
Nov 19, 2025 08:00AM
Oct 17, 2025 09:00AM
Sep 26, 2025 09:00AM
Sep 26, 2025 08:00AM BioVie to Host Live Investor Webinar and Q&A on Oct. 8
Aug 13, 2025 04:05PM
Aug 13, 2025 04:05PM
Aug 11, 2025 04:05PM
Aug 11, 2025 04:05PM
Aug 9, 2025 12:55PM
Aug 7, 2025 08:43PM
Aug 7, 2025 08:43PM BioVie Inc. Announces Pricing of $12 Million Public Offering
Jul 24, 2025 08:01AM
Jul 24, 2025 08:00AM
Jul 22, 2025 09:05AM
Jul 22, 2025 08:00AM
Jul 9, 2025 08:00AM
Jun 26, 2025 08:00AM
Jun 24, 2025 04:05PM BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress
Jun 16, 2025 06:45PM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All